Can-Fite Reports Revenue Growth In 2021, Provides Clinical Update
Can-Fite BioPharma Ltd. (NYSE: CANF) (TASE: CFBI) announced financial results for the year ended December 31, 2021.
The company said that it had $18.9 million in cash, cash equivalents, and short-term deposits, on December 31, 2021.